Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Properties in Hypoparathyroidism: Effects of PTH
NCT00473265Phase 3Completed
- Start
- May 2004
- Primary completion
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of parathyroid hormone 1-84 in hypoparathyroidism. Primary endpoint: Requirements for Calcium Supplementation at 2 years. Started May 2004; status: completed.
02
Drugs
parathyroid hormone 1-84
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on NCT00473265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473265.